About: SARS-CoV2 disrupts clinical research - the role of a rare disease-specific trial network

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: SARS-CoV2 disrupts clinical research - the role of a rare disease-specific trial network Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
title	SARS-CoV2 disrupts clinical research - the role of a rare disease-specific trial network
Creator	Dupont, Bulteel, Bulteel, Veerle Downey, Downey, Damian Dunlevy, Dunlevy, Fiona Dupont, Lieven Van Koningsbruggen-Rietschel, Silke
source	Medline; PMC
abstract	Rare disease patients may suffer delayed access to new drugs as SARS-CoV-2 is disrupting clinical trials. Our survey demonstrates that the European cystic fibrosis clinical trials network is ideally placed to track and address such disruption.
has issue date	2020-08-07(xsd:dateTime)
bibo:doi	10.1183/13993003.02114-2020
bibo:pmid	32764115
has license	cc-by-nc
sha1sum (hex)	c40478d01d23bc18707d55e728067eeb97d0f4f6
schema:url	https://doi.org/10.1183/13993003.02114-2020
resource representing a document's title	SARS-CoV2 disrupts clinical research - the role of a rare disease-specific trial network
has PubMed Central identifier	PMC7411273
has PubMed identifier	32764115
schema:publication	Eur Respir J
resource representing a document's body	covid:c40478d01d23bc18707d55e728067eeb97d0f4f6#body_text
is schema:about of	named entity 'cite' named entity 'rare' named entity 'van' named entity 'doi' named entity 'SARS-CoV2' named entity 'rare disease' named entity 'rare disease' named entity 'clinical research' named entity 'COVID-19' named entity 'clinical trials' named entity 'clinical trial' named entity 'pediatric' named entity 'CFTR' named entity 'gene' named entity 'clinical trials' named entity 'clinical trial' named entity 'CTN' named entity 'clinical trials' named entity 'rare diseases' named entity 'clinical trial' named entity 'rare diseases' named entity 'telehealth' named entity 'CFTR' named entity 'phase 3 trials' named entity 'CFTR' named entity 'rare disease' named entity 'pediatric' named entity 'quality of life' named entity 'CFTR' named entity 'CTN' named entity 'rare diseases' named entity 'CFTR' named entity 'lung function' named entity 'CFTR' named entity 'CFTR' named entity 'CTNs' named entity 'CFTR' named entity 'Europe' named entity 'clinical research' named entity 'March 2020' named entity 'spirometry' named entity 'quarantine' named entity 'quality of life' named entity 'clinical trials' named entity 'SARS-CoV-2' named entity 'SARS-CoV2' named entity 'crowd-sourced' named entity 'pediatric' named entity 'clinical trial' named entity 'clinical trial' named entity '3, 4' named entity 'cystic fibrosis' named entity 'Europe' named entity 'EMA' named entity 'CTN' named entity 'Severe Acute Respiratory Syndrome Coronavirus 2' named entity 'FDA' named entity 'clinical trials' named entity 'Eur' named entity 'SARS-CoV2' named entity 'clinical research' named entity 'clinical research' named entity 'NETWORK' named entity 'TRIAL' named entity 'SARS-CoV2' named entity 'rare disease' named entity 'rare' named entity 'doi' named entity 'SARS' named entity 'network' named entity 'article' named entity 'rare' named entity 'https'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software